New pacemaker connector must be tested before, not after, FDA approval, scientists say
This article was originally published in Clinica
Executive Summary
The US FDA is allowing the sale of potentially dangerous pacemaker equipment, two high-profile cardiologists have alleged.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.